Short Seller Who Bet Against Hims & Hers Now Says Its CEO ‘Wiped The Floor’ With Novo Nordisk
Hunterbrook had shorted Hims in 2024, warning its GLP-1 strategy relied on a regulatory loophole during drug shortages…
Browsing Tag